$1.96
-0.06-2.94%
Pre-Market: 7:40 AM EDT
Comments
Loading...
Innate Pharma Stock Guidance | NASDAQ:IPHA | Benzinga
Innate Pharma issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Innate Pharma SA (IPHA) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Innate Pharma (IPHA)?
There have been no specific sales or earnings guidance reported for Innate Pharma in recent months.
Browse guidance and forecast on all stocks.